Metastatic HER2-negative breast

Clinical trials for Metastatic HER2-negative breast explained in plain language.

Never miss a new study

Get alerted when new Metastatic HER2-negative breast trials appear

Sign up with your email to follow new studies for Metastatic HER2-negative breast, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Engineered t cells take aim at Hard-to-Treat breast cancer

Disease control Ongoing

This study tests the safety of specially prepared T cells that target a protein called mesothelin, found on some breast cancer cells. The cells are collected from the patient's blood, modified in a lab, and then given back along with chemotherapy and another drug. The trial enrol…

Matched conditions: METASTATIC HER2-NEGATIVE BREAST

Phase 1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control

Last updated Jul 18, 2026 00:00 UTC

Metastatic HER2-negative breast

Get alerted when new Metastatic HER2-negative breast trials appear

Engineered t cells take aim at Hard-to-Treat breast cancer